ATE321132T1 - Methode zur herstellung einer immunotropischen antiviralen zusammensetzung - Google Patents

Methode zur herstellung einer immunotropischen antiviralen zusammensetzung

Info

Publication number: ATE321132T1
Authority: AT; Austria
Prior art keywords: solution; dna; hyperchromatic; homogenate; detergent
Prior art date: 2000-12-01

Application number

AT01930355T

Other languages

English (en)

Inventor

Elli Nikolaevna Kaplina

Alexandra Yurievna Ladygina

Valery Yurievich Kaplin

Mihail Yurievich Vainberg

Original Assignee

Elli Nikolaevna Kaplina

Alexandra Yurievna Ladygina

Valery Yurievich Kaplin

Mihail Yurievich Vainberg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-01

Filing date

2001-04-24

Publication date

2006-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20242805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE321132(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-04-24 Application filed by Elli Nikolaevna Kaplina, Alexandra Yurievna Ladygina, Valery Yurievich Kaplin, Mihail Yurievich Vainberg filed Critical Elli Nikolaevna Kaplina

2006-04-15 Application granted granted Critical

2006-04-15 Publication of ATE321132T1 publication Critical patent/ATE321132T1/de

Links

230000000840 anti-viral effect Effects 0.000 title abstract 2
230000000686 immunotropic effect Effects 0.000 title abstract 2
239000000243 solution Substances 0.000 abstract 3
239000003599 detergent Substances 0.000 abstract 2
230000002895 hyperchromatic effect Effects 0.000 abstract 2
241000881711 Acipenser sturio Species 0.000 abstract 1
241000972773 Aulopiformes Species 0.000 abstract 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
241000450599 DNA viruses Species 0.000 abstract 1
241000287828 Gallus gallus Species 0.000 abstract 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
UCUJUFDOQOJLBE-UHFFFAOYSA-N [Cl].[Ca] Chemical compound [Cl].[Ca] UCUJUFDOQOJLBE-UHFFFAOYSA-N 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
244000309466 calf Species 0.000 abstract 1
241001493065 dsRNA viruses Species 0.000 abstract 1
230000001747 exhibiting effect Effects 0.000 abstract 1
235000013861 fat-free Nutrition 0.000 abstract 1
210000004185 liver Anatomy 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
235000019515 salmon Nutrition 0.000 abstract 1
239000011780 sodium chloride Substances 0.000 abstract 1
239000002594 sorbent Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
210000001541 thymus gland Anatomy 0.000 abstract 1
229910052723 transition metal Inorganic materials 0.000 abstract 1
150000003624 transition metals Chemical class 0.000 abstract 1
238000002604 ultrasonography Methods 0.000 abstract 1
229910052725 zinc Inorganic materials 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT01930355T 2000-12-01 2001-04-24 Methode zur herstellung einer immunotropischen antiviralen zusammensetzung ATE321132T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
RU2000130036/14A RU2172632C1 (ru)	2000-12-01	2000-12-01	Способ получения иммунотропного противовирусного препарата

Publications (1)

Publication Number	Publication Date
ATE321132T1 true ATE321132T1 (de)	2006-04-15

Family

ID=20242805

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01930355T ATE321132T1 (de)	2000-12-01	2001-04-24	Methode zur herstellung einer immunotropischen antiviralen zusammensetzung

Country Status (8)

Country	Link
EP (1)	EP1338281B1 (de)
AT (1)	ATE321132T1 (de)
AU (1)	AU2001256888A1 (de)
BR (1)	BR0107998A (de)
CA (1)	CA2399310C (de)
DE (1)	DE60118175T2 (de)
RU (1)	RU2172632C1 (de)
WO (1)	WO2002043740A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2236853C1 (ru) *	2003-12-30	2004-09-27	Каплина Элли Николаевна	Способ производства иммунотропного стерильного апирогенного толерантного препарата на основе натриевой соли низкомолекулярной нативной дезоксирибонуклеиновой кислоты
RU2268730C1 (ru) *	2004-04-26	2006-01-27	Общество с ограниченной ответственностью "БиоМодуль"	Способ получения натриевой соли гетерогенной дезоксирибонуклеиновой кислоты (днк)
RU2309759C1 (ru) *	2006-11-03	2007-11-10	Элли Николаевна Каплина	Способ получения апирогенного иммуномодулятора
RU2519349C1 (ru) *	2013-02-26	2014-06-10	Государственное научное учреждение Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии Российской академии сельскохозяйственных наук (ГНУ ВНИВИПФиТ Россельхозакадемии)	Способ комплексного лечения мастита у лактирующих коров
RU2739186C1 (ru) *	2020-04-21	2020-12-21	Александр Евгеньевич Ладыгин	Способ получения противовирусного лекарственного средства

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ209840A (en) *	1983-10-17	1988-11-29	Kaji Akira	A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action
WO1987001284A1 (en) *	1985-08-26	1987-03-12	United States Of America, Represented By The Unite	Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
US5380830A (en) *	1989-09-18	1995-01-10	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Molecular clones of bovine immunodeficiency-like virus
WO1993010793A1 (fr) *	1991-12-03	1993-06-10	Jury Petrovich Vainberg	Agent antiviral
US5547684A (en) *	1993-02-10	1996-08-20	Pharmec Company	Cosmetic composition containing a DNA-sodium salt and methods of making and using the same
RU2005724C1 (ru) *	1993-04-29	1994-01-15	Юрий Петрович Вайнберг	Способ производства натриевой соли дезоксирибонуклеиновой кислоты из животного сырья и установка для его осуществления
RU2043767C1 (ru) *	1993-05-24	1995-09-20	Научно-производственное предприятие "Фармэк"	Способ подавления вич-инфекции
ATE212848T1 (de) *	1993-05-24	2002-02-15	Np Predpr Sfarmeks	Niedermolekulare dna aus störmilch, methode zur gewinnung der dna und ein pharmazeutisches präparat darauf basierend
RU2041885C1 (ru) *	1993-05-31	1995-08-20	Научно-производственный центр "Фармзащита" МЗ РФ	Способ получения порошка натриевой соли дезоксирибонуклеиновой кислоты из молок рыб
RU2055837C1 (ru) *	1994-05-31	1996-03-10	Научно-производственный центр "Фармзащита"	Способ получения стерильного раствора натриевой соли дезоксирибонуклеиновой кислоты
RU2108797C1 (ru) *	1994-11-09	1998-04-20	Закрытое акционерное общество "Фаркавер"	Способ получения антивирусного препарата на основе днк
US5932717A (en) *	1994-09-29	1999-08-03	Asafov; Alexandr V.	Methods of obtaining DNA-RNA hybrids from sturgeon milt
RU2136286C1 (ru) *	1996-01-22	1999-09-10	Каплина Элли Николаевна	Противовирусное средство к рнк- и днк-содержащим вирусам
RU2158592C1 (ru) *	1999-12-29	2000-11-10	Каплина Элли Николаевна	Противовирусное иммунотропное средство

2000
- 2000-12-01 RU RU2000130036/14A patent/RU2172632C1/ru active
2001
- 2001-04-24 AT AT01930355T patent/ATE321132T1/de active
- 2001-04-24 EP EP01930355A patent/EP1338281B1/de not_active Expired - Lifetime
- 2001-04-24 WO PCT/RU2001/000171 patent/WO2002043740A1/ru not_active Ceased
- 2001-04-24 BR BR0107998-0A patent/BR0107998A/pt not_active IP Right Cessation
- 2001-04-24 DE DE60118175T patent/DE60118175T2/de not_active Expired - Lifetime
- 2001-04-24 CA CA2399310A patent/CA2399310C/en not_active Expired - Fee Related
- 2001-04-24 AU AU2001256888A patent/AU2001256888A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2002043740A1 (en)	2002-06-06
DE60118175T2 (de)	2007-01-25
EP1338281A4 (de)	2004-03-24
CA2399310C (en)	2012-09-18
EP1338281B1 (de)	2006-03-22
EP1338281A1 (de)	2003-08-27
AU2001256888A1 (en)	2002-06-11
DE60118175D1 (de)	2006-05-11
BR0107998A (pt)	2002-10-29
RU2172632C1 (ru)	2001-08-27
CA2399310A1 (en)	2002-06-06

Similar Documents

Publication	Publication Date	Title
DE69919019D1 (de)	2004-09-02	Verfahren zur herstellung einer proteinzusammenzetzung und einer diese enthaltenden säuglingsnahrung
BR0108734A (pt)	2002-12-17	Composições antimicrobiais ácidas para tratar alimento e superfìcies de contato do alimento e métodos para uso das mesmas
ATE485371T1 (de)	2010-11-15	Varianten des menschlichen koagulationsfaktors vii
AU9078401A (en)	2002-03-26	Antimicrobial peptides and methods of use
ATE347910T1 (de)	2007-01-15	Zusammensetzungen zur behandlung von ischamischem gewebe
BR0207502A (pt)	2004-03-09	Compostos, enanciÈmeros, composição farmacêutica, uso de compostos, e, processo para a fabricação de compostos
AR014261A1 (es)	2001-02-07	Compuestos hipolipidemicos de benzotiazepina, composiciones y proceso para su preparacion
KR890004725A (ko)	1989-05-09	신규 방법
DE69418403D1 (de)	1999-06-17	Verfahren zur Herstellung von Aminosäureteilchen
PT94680A (pt)	1991-04-18	Processo para a obtencao de uma proteina tendo actividade de urato oxidase gene recombinante que a codifica vector de expressao portador deste gene microorganismos procariotas e celulas eucariotas transformados por este vector de expressao
DE60118175D1 (de)	2006-05-11	Methode zur herstellung einer immunotropischen antiviralen zusammensetzung
WO2004064732A3 (en)	2006-04-20	The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
DE60102147D1 (de)	2004-04-01	Anti-gefrier proteine, deren herstellung und verwendung
BR0214702A (pt)	2004-08-31	Métodos e composições para emprego em criação de animal de estimação
PT1140113E (pt)	2004-03-31	Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos
BR0313436A (pt)	2005-07-12	Produtos alimentìcios contendo proteìna animal e possuindo retenção melhorada de umidade
ATE372687T1 (de)	2007-09-15	Verfahren zur verbesserung von proteinprodukten
DE69007546D1 (de)	1994-04-28	Haarbehandlungszusammensetzung.
JP3790671B2 (ja)	2006-06-28	人体および動植物生理活性促進物ならびにその製造方法
BR9814958A (pt)	2000-10-03	Proteìna de cimento de tecido, composição farmacêutica, uso da proteìna de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido, molécula de ácido nucleico, vetor de expressão ou de clonagem, célula hospedeira, e, animal transgênico
AR027246A1 (es)	2003-03-19	Procedimiento para la preparacion de acetil-amidiniofenilalanil-ciclohexilglicil-piridinioalaninamidas.
ATE283020T1 (de)	2004-12-15	Biomaterial zur behandlung von zahnfäule
BR0213953A (pt)	2004-08-31	Composição farmacêutica, kit de partes, uso de fator vii ou um polipeptìdeo relacionado com fator vii em combinação com um fator v ou um polipeptìdeo relacionado com fator v, uso de uma composição, métodos para tratar episódios de sangramento em um sujeito, para reduzir o tempo de coagulação, para intensificar hemóstase, para prolongar o tempo de lise de coágulos em um sujeito, e para incrementar a resistência do coágulo em um sujeito, kit contendo um tratamento para episódios de sangramento
EP1224871A3 (de)	2003-01-22	Zubereitungen auf Basis von Padina Algen oder ihren Extrakten, und Nahrungsmittel oder für die Kultur von Mollusken oder Arthropoden Kulturverwendungen
ATE245438T1 (de)	2003-08-15	Verwendung von oligomerem matrixprotein aus knorpel zur behandlung von rheumatoider arthritis

Legal Events

Date

Code

Title

Description

2006-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1338281

Country of ref document: EP